Samsung Biologics

samsungbiologics.com · Incheon, Republic of Korea

Samsung Biologics is a contract development and manufacturing organization that provides end-to-end biopharmaceutical services including cell line development, process development, clinical and commercial biologics manufacturing, and related quality and regulatory support for global pharmaceutical and biotech companies. It operates large-scale biologics manufacturing facilities and generates revenue through fee-for-service and long-term manufacturing and development contracts.

Revenue
$1B+
Employees
5,001+
Founded
2011
Headquarters
Incheon, Republic of Korea

Samsung Biologics customers on Arbolus

Total customers 6 6 current · 0 former
Reviews growth 3 new reviews since Jan 2026

Customers who reviewed Samsung Biologics

Seniority of Samsung Biologics customers

Most people who reviewed Samsung Biologics hold C-Suite roles (67%), followed by Manager (17%) and Director (17%).

  • C-Suite 67%
  • Manager 17%
  • Director 17%

Customers sample

Product Leader Manager NPS 7 Will renew
Strategy Leader C-Suite NPS 10
Operations Manager C-Suite NPS 9 Will renew

Employer names and spend open once the report publishes.

What 6 Arbolus experts think of Samsung Biologics

Overall sentiment: Positive

NPS distribution is bimodal, with 67% of responses at the high end (9–10) and one outlier (3), yielding generally favorable sentiment. Among experts with renewal intent data, two out of three indicate willingness to renew, while one is unsure, mirroring the NPS pattern. Stickiness is stronger among those with more than one year of usage, as evidenced by higher NPS scores in this group. Key themes include high satisfaction among long-term operational users and renewal hesitancy concentrated among Influencer roles.

Tell us when the Samsung Biologics report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

50 Net Promoter Score, from 6 scored reviews
  • Promoters 4
  • Passives 1
  • Detractors 1

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 67%
  • Will renew 2
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Manager 100% 1 answer
  • 8/10 Average score from customers who will renew
  • 3/10 Average score from undecided customers

For people who use Samsung Biologics

Do you use Samsung Biologics at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 6 customers of Samsung Biologics have already contributed

Takes a few minutes. Your identity stays anonymous.